Successful treatment with rituximab in a refractory Stiff-person syndrome;Efficacité du rituximab dans le traitement d'un Syndrome de Stiff person réfractaire

Revue Neurologique

Volumn 168, Issue 4, 2012, Pages 375-378

  Sevy, A ^a   Franques, J ^a   Chiche, L ^b   Pouget, J ^a   Attarian, S ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Glutamate decarboxylase; Rituximab; Stiff person syndrome

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MUSCLE SPASM; MUSCLE STIFFNESS; STIFF MAN SYNDROME;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; IMMUNOTHERAPY; MIDDLE AGED; REMISSION INDUCTION; SALVAGE THERAPY; STIFF-PERSON SYNDROME; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84860011229     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2011.09.008     Document Type: Article

References (11)

1. Bacorro EA, Tehrani R. Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab. J Clin Rheumatol 2010;16:237-9.
2. Baker M, Isaacs J. Treatment of stiff person syndrome with rituximab. J Neurol Neurosurg Psychiatry 2005;76: 999-1001. (Pubitemid 40909562)
3. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001;345(26):1870-6. (Pubitemid 33716561)
4. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998;44:194-201. (Pubitemid 28374107)
5. Dupond JL, Essalmi L, Gil H, Meaux-Ruault N, Hafsaoui C. Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis. J clin Neurosci 2010;17:389-91.
6. Katoh N, Matsuda M, Ishii W, Morita H, Ikeda S. Successful treatment with rituximab in a patient with stiff-person syndrome complicated with dysthyroid ophtalmopathy. Inter Med 2010;49:237-41.
7. Nemmi R, Carriatti IM, Gironi M, et al. Stiff person syndrome does not always occur with maternal passive transfert of GAD 65 antibodies. Neurology 2005;62:2101-2. (Pubitemid 38738231)
8. Rizzi M, Knoth R, Hampe CS, Lorenz P, Gougeon ML, Lemercier B, et al. Long-lived plasma cells and memory B cells produce pathogenic anti- GAD65 autoantibodies in Stiff Person Syndrome. PLoS One 2010;5:e10838.
9. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988;318:1012-20. (Pubitemid 18095005)
10. Tony HP, Burmester G, Schulze-Koops H, Grunke M, Henes J, Kotter I, et al. Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID). Arthritis Res Ther 2011;13:R75.
11. Venhoff N, Rizzi M, Salzer U, Bossaller L, Thoden J, Eibel H, et al. Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a doubleblind, randomised, placebo controlled crossover study. Ann Rheum 2009;68:1506-8.